The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase II study of perioperative therapy for patients with resectable and borderline-resectable pancreatic adenocarcinoma.
Andrew L. Coveler
No relevant relationships to disclose
Venu Gopal Pillarisetty
No relevant relationships to disclose
Grace Gyurkey
No relevant relationships to disclose
Wui-Jin Koh
No relevant relationships to disclose
Melissa Upton
No relevant relationships to disclose
Carlos Cuevas
No relevant relationships to disclose
Theodore Gooley
No relevant relationships to disclose
E. Gabriela Chiorean
No relevant relationships to disclose
Veena Shankaran
No relevant relationships to disclose
William Proctor Harris
No relevant relationships to disclose
James Oh Park
No relevant relationships to disclose
Gary N. Mann
No relevant relationships to disclose
David R. Byrd
No relevant relationships to disclose
Stacey Balas
No relevant relationships to disclose
Samuel H. Whiting
No relevant relationships to disclose